# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Craig-Hallum analyst Alexander Nowak upgrades CareDx (NASDAQ:CDNA) from Hold to Buy and raises the price target from $12 to ...
Stephens & Co. analyst Mason Carrico reiterates CareDx (NASDAQ:CDNA) with a Overweight and maintains $15 price target.
CareDx (NASDAQ:CDNA) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.27) by 37....
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...